New York, NY— LAWFUEL – The Law News Network – Kirkpatrick & Lockhart Nicholson Graham LLP (K&LNG) is pleased to announce the creation of its Stem Cell Technology practice.
K&LNG’s Stem Cell Technology practice combines the knowledge and experience of lawyers from diverse areas of the firm, including its international corporate, food and drug, and intellectual property practice groups, to respond to legal issues unique to stem cell technology, including its development and commercialization.
Thomas J. Turano, a partner in K&LNG’s Stem Cell Technology practice, said: “Stem cell research has reached a point where the results of the research are moving from the laboratory to the clinic. Current stem-cell related legal work focuses on research funding, intellectual property protection, insurance coverage and regulatory compliance. However as advancements continue, legal work will focus on the sector’s moving into a more commercial realm and will be governed by an entirely different set of state, national and international rules and regulations. We are pleased to offer such dedicated legal services to our clients to help them continue their work and adapt to change in this dynamic and emerging field.”
Peter J. Kalis, Chair of K&LNG’s Management Committee, said: “Our clients in the life sciences and biotechnology industries will face a new set of legal needs and considerations as stem cell research and technology continues in its path toward commercialization. The ability of K&LNG’s Stem Cell Technology lawyers to serve those clients draws on our established areas of corporate, intellectual property and food and drug law. Combined with our international resources, K&LNG is well positioned to advise its clients as they navigate this highly complex area.”
Kirkpatrick & Lockhart Nicholson Graham (K&LNG) has approximately 1000 lawyers and represents entrepreneurs, growth and middle market companies, capital markets participants, and leading FORTUNE 100 and FTSE 100 global corporations nationally and internationally.
K&LNG is a combination of two limited liability partnerships, each named Kirkpatrick & Lockhart Nicholson Graham LLP, one qualified in Delaware, U.S.A. and practicing from offices in Boston, Dallas, Harrisburg, Los Angeles, Miami, Newark, New York, Palo Alto, Pittsburgh, San Francisco and Washington and one incorporated in England practicing from the London office.